Pathalys Pharma
Raleigh, United States · $255.0M raised
- Headquarters
- Raleigh, North Carolina
- Business Model
- B2B
- Website
- pathalys.com
- Total Funding
- $255.0M
- Last Round
- $105.0M Series BAug 2024
- Rounds
- 2
About
Late-stage clinical biopharmaceutical company developing enhanced therapeutics to improve patient management of chronic diseases.
Summary
Pathalys Pharma is a Biotech company based in Raleigh, United States. It has raised $255.0M in total across 2 rounds, most recently a $105.0M Series B round in Aug 2024. Investors include Abingworth Bioventures, OrbiMed and J.P. Morgan Life Sciences Private Capital.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company